CLINICAL TRIALS PROFILE FOR BENZACLIN
✉ Email this page to a colleague
All Clinical Trials for BENZACLIN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01138514 ↗ | Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels | Completed | Padagis LLC | Phase 3 | 2009-10-01 | The purpose of this study is to compare the efficacy and safety profiles of Perrigo Israel Pharmaceuticals, Ltd. Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel and Benzaclin® Topical Gel (Clindamycin- Benzoyl Peroxide Gel). |
| NCT01138514 ↗ | Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels | Completed | Perrigo Company | Phase 3 | 2009-10-01 | The purpose of this study is to compare the efficacy and safety profiles of Perrigo Israel Pharmaceuticals, Ltd. Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel and Benzaclin® Topical Gel (Clindamycin- Benzoyl Peroxide Gel). |
| NCT01237821 ↗ | Comparing OTC Acne Treatment to Prescription Regimen | Completed | Loreal USA | N/A | 2010-10-01 | This research is being done to find out the safety and efficacy of two acne creams, Effaclar and Benzaclin when used twice daily with a topical retinoid. Effaclar and Benzaclin are FDA approved for the treatment of acne. |
| NCT01237821 ↗ | Comparing OTC Acne Treatment to Prescription Regimen | Completed | Milton S. Hershey Medical Center | N/A | 2010-10-01 | This research is being done to find out the safety and efficacy of two acne creams, Effaclar and Benzaclin when used twice daily with a topical retinoid. Effaclar and Benzaclin are FDA approved for the treatment of acne. |
| NCT02465632 ↗ | To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris. | Completed | Glenmark Pharmaceuticals Ltd. India | Phase 3 | 2015-04-01 | This is a randomized, double-blind, multiple-site, placebo-controlled, parallel-group study, designed to compare the efficacy and safety of generic Clindamycin 1%/ Benzoyl peroxide 5% topical gel (Glenmark Generics, Ltd), and the marketed product BenzaClin® Topical Gel, Clindamycin 1%/ Benzoyl peroxide 5% (Valeant Pharmaceuticals, US) in the treatment of acne vulgaris. |
| NCT02595034 ↗ | A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris | Completed | Taro Pharmaceuticals USA | Phase 1 | 2015-01-01 | This study is to evaluate the therapeutic equivalence and safety of Clindamycin and Benzoyl Peroxide Gel 1%/5% and BenzaClin® (clindamycin 1%/benzoyl peroxide 5%) Topical Gel |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BENZACLIN
Condition Name
Clinical Trial Locations for BENZACLIN
Trials by Country
Clinical Trial Progress for BENZACLIN
Clinical Trial Phase
Clinical Trial Sponsors for BENZACLIN
Sponsor Name
